Brandon Couillard
Stock Analyst at Wells Fargo
(4.52)
# 268
Out of 5,117 analysts
174
Total ratings
62.14%
Success rate
17.34%
Average return
Main Sectors:
Stocks Rated by Brandon Couillard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Equal-Weight | $385 → $415 | $386.06 | +7.50% | 7 | Dec 15, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Overweight | $635 → $675 | $580.74 | +16.23% | 8 | Dec 15, 2025 | |
| RVTY Revvity | Maintains: Equal-Weight | $102 → $107 | $96.75 | +10.59% | 3 | Dec 15, 2025 | |
| RGEN Repligen | Maintains: Overweight | $175 → $190 | $166.21 | +14.31% | 3 | Dec 15, 2025 | |
| MTD Mettler-Toledo International | Maintains: Equal-Weight | $1,400 → $1,450 | $1,420.10 | +2.11% | 7 | Dec 15, 2025 | |
| MLAB Mesa Laboratories | Maintains: Equal-Weight | $75 → $83 | $80.47 | +3.14% | 4 | Dec 15, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Overweight | $4 → $4.5 | $3.26 | +38.04% | 2 | Dec 15, 2025 | |
| DHR Danaher | Maintains: Equal-Weight | $230 → $240 | $230.32 | +4.20% | 5 | Dec 15, 2025 | |
| BRKR Bruker | Maintains: Overweight | $48 → $55 | $48.01 | +14.56% | 7 | Dec 15, 2025 | |
| NTRA Natera | Maintains: Equal-Weight | $190 → $205 | $233.74 | -12.30% | 3 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $93 → $120 | $102.98 | +16.53% | 2 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $140 → $155 | $133.79 | +15.85% | 6 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $14 → $18 | $19.48 | -7.60% | 4 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $110 | $89.30 | +23.18% | 1 | Dec 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $150 → $175 | $138.39 | +26.45% | 25 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $90 → $105 | $101.57 | +3.38% | 19 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $59 → $70 | $59.22 | +18.20% | 2 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $6.5 | $6.48 | +0.31% | 3 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $265 → $340 | $303.88 | +11.89% | 13 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $265 → $340 | $304.17 | +11.78% | 13 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $19 → $16 | $11.43 | +39.98% | 5 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $260 | $158.37 | +64.17% | 11 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $77 → $80 | $76.13 | +5.08% | 6 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $30 → $23 | $21.99 | +4.59% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $1.98 | +556.57% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.42 | - | 11 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $1.63 | +574.85% | 2 | Oct 13, 2017 |
Waters
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $385 → $415
Current: $386.06
Upside: +7.50%
Thermo Fisher Scientific
Dec 15, 2025
Maintains: Overweight
Price Target: $635 → $675
Current: $580.74
Upside: +16.23%
Revvity
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $102 → $107
Current: $96.75
Upside: +10.59%
Repligen
Dec 15, 2025
Maintains: Overweight
Price Target: $175 → $190
Current: $166.21
Upside: +14.31%
Mettler-Toledo International
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $1,400 → $1,450
Current: $1,420.10
Upside: +2.11%
Mesa Laboratories
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $75 → $83
Current: $80.47
Upside: +3.14%
Maravai LifeSciences Holdings
Dec 15, 2025
Maintains: Overweight
Price Target: $4 → $4.5
Current: $3.26
Upside: +38.04%
Danaher
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $230 → $240
Current: $230.32
Upside: +4.20%
Bruker
Dec 15, 2025
Maintains: Overweight
Price Target: $48 → $55
Current: $48.01
Upside: +14.56%
Natera
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $190 → $205
Current: $233.74
Upside: -12.30%
Dec 15, 2025
Maintains: Overweight
Price Target: $93 → $120
Current: $102.98
Upside: +16.53%
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $140 → $155
Current: $133.79
Upside: +15.85%
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $14 → $18
Current: $19.48
Upside: -7.60%
Dec 1, 2025
Initiates: Equal-Weight
Price Target: $110
Current: $89.30
Upside: +23.18%
Nov 25, 2025
Maintains: Overweight
Price Target: $150 → $175
Current: $138.39
Upside: +26.45%
Nov 24, 2025
Downgrades: Hold
Price Target: $90 → $105
Current: $101.57
Upside: +3.38%
Nov 6, 2025
Maintains: Overweight
Price Target: $59 → $70
Current: $59.22
Upside: +18.20%
Nov 5, 2025
Maintains: Equal-Weight
Price Target: $6 → $6.5
Current: $6.48
Upside: +0.31%
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $265 → $340
Current: $303.88
Upside: +11.89%
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $265 → $340
Current: $304.17
Upside: +11.78%
Aug 4, 2025
Maintains: Overweight
Price Target: $19 → $16
Current: $11.43
Upside: +39.98%
Jan 23, 2025
Maintains: Buy
Price Target: $285 → $260
Current: $158.37
Upside: +64.17%
Jan 23, 2025
Maintains: Hold
Price Target: $77 → $80
Current: $76.13
Upside: +5.08%
Feb 9, 2024
Downgrades: Hold
Price Target: $30 → $23
Current: $21.99
Upside: +4.59%
Jul 13, 2021
Initiates: Buy
Price Target: $13
Current: $1.98
Upside: +556.57%
Nov 2, 2017
Downgrades: Hold
Price Target: n/a
Current: $2.42
Upside: -
Oct 13, 2017
Maintains: Buy
Price Target: $9 → $11
Current: $1.63
Upside: +574.85%